| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | MARA | United States | $11.83 | $919,173,000.00 | Buy | 14 | N/A |
#2 | CWK | United States | $15.58 | $10,003,900,000.00 | Buy | 8 | 2018 |
#3 | T | United States | $24.33 | $124,480,000,000.00 | Buy | 20 | N/A |
#4 | CWEN | United States | $32.65 | $1,375,000,000.00 | Strong Buy | 8 | 2013 |
#5 | AMX | Mexico | $21.38 | $51,012,503,011.00 | Buy | 6 | 2001 |
#6 | CTRE | United States | $35.85 | $428,478,000.00 | Buy | 6 | N/A |
#7 | TME | China | $18.20 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#8 | BZ | China | $20.24 | $1,125,491,208.00 | Strong Buy | 4 | 2021 |
#9 | FE | United States | $44.07 | $14,283,000,000.00 | Buy | 14 | N/A |
#10 | DOCS | United States | $43.99 | $621,329,000.00 | Buy | 21 | 2021 |
#11 | TTD | United States | $37.04 | $2,790,505,000.00 | Buy | 35 | 2016 |
#12 | DX | United States | $13.53 | $230,447,000.00 | Buy | 4 | N/A |
#13 | PPL | United States | $33.39 | $8,979,000,000.00 | Buy | 10 | N/A |
#14 | OHI | United States | $43.58 | $1,150,200,000.00 | Buy | 10 | N/A |
#15 | BKR | United States | $47.40 | $27,711,000,000.00 | Strong Buy | 18 | N/A |
#16 | OGE | United States | $42.56 | $3,294,800,000.00 | Buy | 9 | N/A |
#17 | CGNX | United States | $36.79 | $971,705,000.00 | Buy | 12 | 1989 |
#18 | DINO | United States | $49.44 | $26,905,000,000.00 | Buy | 12 | N/A |
#19 | WTRG | United States | $37.64 | $2,379,887,000.00 | Buy | 7 | N/A |
#20 | AMRC | United States | $32.12 | $1,883,767,000.00 | Buy | 9 | 2010 |
#21 | NI | United States | $41.57 | $6,327,100,000.00 | Buy | 9 | N/A |
#22 | VIV | Brazil | $12.24 | $10,989,199,704.00 | Buy | 4 | 1998 |
#23 | CNP | United States | $37.23 | $9,114,000,000.00 | Buy | 12 | N/A |
#24 | NTST | United States | $17.66 | $186,604,000.00 | Strong Buy | 11 | 2020 |
#25 | LENZ | United States | $24.52 | $17,500,000.00 | Strong Buy | 4 | 2021 |
#26 | LEGN | United States | $23.02 | $909,045,000.00 | Strong Buy | 13 | 2020 |
#27 | WBI | United States | $21.75 | $733,296,000.00 | Buy | 8 | 2025 |
#28 | CNTA | United Kingdom | $27.25 | $15,000,000.00 | Strong Buy | 11 | 2021 |
#29 | SGRY | United States | $16.05 | $3,288,100,000.00 | Buy | 8 | 2015 |
#30 | AGIO | United States | $27.62 | $44,791,000.00 | Buy | 9 | 2013 |
#31 | BLFS | United States | $24.89 | $100,144,000.00 | Strong Buy | 4 | 1989 |
#32 | URGN | United States | $22.35 | $96,516,000.00 | Strong Buy | 8 | 2017 |
#33 | OMDA | United States | $15.37 | $232,342,000.00 | Strong Buy | 9 | 2025 |
#34 | BEP | Canada | $28.14 | $6,300,000,000.00 | Buy | 10 | N/A |
#35 | DYN | United States | $19.44 | $0.00 | Strong Buy | 16 | 2020 |
#36 | NTNX | United States | $47.25 | $2,617,547,000.00 | Buy | 16 | 2016 |
#37 | AMLX | United States | $13.06 | -$665,000.00 | Strong Buy | 7 | 2022 |
#38 | PTRN | United States | $12.76 | $2,293,676,000.00 | Strong Buy | 10 | 2025 |
#39 | DNLI | United States | $17.34 | $0.00 | Strong Buy | 14 | 2017 |
#40 | ELVN | United States | $18.76 | $0.00 | Strong Buy | 5 | 2020 |
#41 | PHAT | United States | $14.59 | $147,190,000.00 | Strong Buy | 6 | 2019 |
#42 | XPEV | China | $19.18 | $9,912,782,208.00 | Buy | 6 | 2020 |
#43 | PHR | United States | $16.05 | $463,205,000.00 | Strong Buy | 17 | 2019 |
#44 | WYFI | United States | $18.62 | $70,202,034.00 | Strong Buy | 7 | 2025 |
#45 | QURE | Netherlands | $19.68 | $15,751,000.00 | Strong Buy | 12 | 2007 |
#46 | SOUN | United States | $12.02 | $148,404,000.00 | Buy | 7 | N/A |
#47 | S | United States | $15.00 | $955,646,000.00 | Buy | 29 | 2021 |
#48 | IMTX | Germany | $10.05 | $99,445,031.00 | Strong Buy | 5 | N/A |
#49 | KURA | United States | $10.47 | $104,029,000.00 | Buy | 11 | N/A |
#50 | ADPT | United States | $15.43 | $252,754,000.00 | Strong Buy | 10 | 2019 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $50 to Buy (December 12, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.